Biontech Wants Approval for Its Vaccine for Children Between 5 and 11 Year-Olds

Biontech Wants Approval for Its Vaccine for Children Between 5 and 11 Year-Olds
SHARE

BioNTech will soon request approval for using its COVID-19 vaccine on children as young as five years old. They want to implement it all over the world by the next few weeks. They are preparing for the launch, according to two top executives.

Chief Medical Officer Oezlem Tuereci stated: “Already over the next few weeks we will file the results of our trial in five to 11 year olds with regulators across the world and will request approval of the vaccine in this age group, also here in Europe.”

BioNTech made the team with Pzifer for the vaccine, and they are sure they will get the approval to vaccinate children under 12 in Western countries. They will file its regulatory dossier for 5 to 11-year-olds this month. They have also presented their plan to get approval for children aged six months to 2 years. They want to get it done until later this year.

Tuereci has also stated that the final production phases are adjusted to bottle for the pediatric versions of its Comirnaty vaccine. It is approved for adults and kids of 12 years old. Chief Executive Ugur Sahin said that they have it all under control, and everything is going according to the plan.

Moderna also comes with news, a trial testing for its shot for children between 6 and 11 years old. They are currently working on dosage for infants of 6 months.

China has approved the use of Sinovac’s vaccine in children of three years old. Chile has approved the use of the vaccine in kids older than six years old. Israel has decided that if kids of 5 years old or older suffer from conditions that make them vulnerable to COVID-19, they can get the Pfizer shot.


SHARE
Jeffrey Olmsted

Jeffrey likes to write about health and fitness topics, being a champion fitness instructor in the past.

Share this post

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.